Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
Delayed Quote. Delayed Nyse - 11/29 04:10:00 pm
110.71 USD   +1.09%
11/24INSIDER BUY : Edwards Lifesciences
MT
11/22INSIDER SELL : Edwards Lifesciences
MT
11/10INSIDER SELL : Edwards Lifesciences
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about EDWARDS LIFESCIENCES CORPORATION
11/24INSIDER BUY : Edwards Lifesciences
MT
11/22INSIDER SELL : Edwards Lifesciences
MT
11/10INSIDER SELL : Edwards Lifesciences
MT
11/08INSIDER SELL : Edwards Lifesciences
MT
11/06Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement Program
PR
11/06Edwards Lifesciences Corporation Announces Six-Month Data from Transcatheter Tricuspid ..
CI
11/05TAVR with SAPIEN 3 Demonstrated as Economically Dominant Treatment Strategy Compared to..
PR
10/29TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 5, 2021.
CI
10/29TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 8, 2019.
CI
10/28Oppenheimer Adjusts Edwards Lifesciences PT to $122 From $120, Maintains Outperform Rat..
MT
10/28Citigroup Adjusts Edwards Lifesciences' Price Target to $120 from $113, Keeps Neutral R..
MT
10/28Raymond James Adjusts Edwards Lifesciences' Price Target to $127 from $122, Keeps Outpe..
MT
10/28Credit Suisse Raises Edwards Lifesciences' PT to $130 from $126 After Q3 Results Beat E..
MT
10/28Wells Fargo Adjusts Edwards Lifesciences' Price Target to $126 From $115, Keeps Equal-W..
MT
10/27Edwards Lifesciences Reports Higher Q3 EPS, Revenue; Sets Full-Year Guidance
MT
More most relevant news
All news about EDWARDS LIFESCIENCES CORPORATION
11/24INSIDER BUY : Edwards Lifesciences
MT
11/22INSIDER SELL : Edwards Lifesciences
MT
11/10INSIDER SELL : Edwards Lifesciences
MT
11/08INSIDER SELL : Edwards Lifesciences
MT
11/06Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement Program
PR
11/06Edwards Lifesciences Corporation Announces Six-Month Data from Transcatheter Tricuspid ..
CI
11/05TAVR with SAPIEN 3 Demonstrated as Economically Dominant Treatment Strategy Compared to..
PR
10/29EDWARDS LIFESCIENCES CORP Management's Discussion and Analysis of Financial Condition ..
AQ
10/29TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 8, 2019.
CI
10/29TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 5, 2021.
CI
More news
News in other languages on EDWARDS LIFESCIENCES CORPORATION
11/24ACHATS D'INITIÉS : Edwards Lifesciences
11/22VENTE PAR DES INITIÉS : Edwards Lifesciences
11/10VENTE PAR DES INITIÉS : Edwards Lifesciences
11/08VENTE PAR DES INITIÉS : Edwards Lifesciences
10/27Edwards Lifesciences annonce une hausse de son bénéfice par action et de son chiffre d'..
10/27Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION affiche un chiffre d'affaires de 1..
10/27Edwards Lifesciences Corporation réaffirme ses prévisions de résultats pour l'ensemble ..
10/27HISTORIQUE DES RÉACTIONS AUX RÉSULTA : Edwards Lifesciences Corp, indicateur de suivi de 2..
09/16VENTE PAR DES INITIÉS : Edwards Lifesciences
2019Les valeurs à suivre à Wall Street
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
10/28Oppenheimer Adjusts Edwards Lifesciences PT to $122 From $120, Maintains Outperform Rat..
MT
10/28Citigroup Adjusts Edwards Lifesciences' Price Target to $120 from $113, Keeps Neutral R..
MT
10/28Raymond James Adjusts Edwards Lifesciences' Price Target to $127 from $122, Keeps Outpe..
MT
10/28Credit Suisse Raises Edwards Lifesciences' PT to $130 from $126 After Q3 Results Beat E..
MT
10/28Wells Fargo Adjusts Edwards Lifesciences' Price Target to $126 From $115, Keeps Equal-W..
MT
More recommendations
Press releases
11/06Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement Program
PR
11/05TAVR with SAPIEN 3 Demonstrated as Economically Dominant Treatment Strategy Compared to..
PR
10/29EDWARDS LIFESCIENCES CORP Management's Discussion and Analysis of Financial Condition ..
AQ
10/27EDWARDS LIFESCIENCES : Q3 Earnings Snapshot
AQ
10/27EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS - Form 8-K
PU
More press releases
Upcoming event on EDWARDS LIFESCIENCES CORPORATION
12/08/21